Presentations we supply
- Injection 60 mg
- Injection 120 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for DenosumabReference information
Summarised from the product information for Prolia and Xgeva. Always follow the product information approved in your own country.
- Active substance
- Denosumab
- Pharmacotherapeutic group
- Drugs for treatment of bone diseases, other drugs affecting bone structure and mineralisation (ATC code M05BX04)
- Authorised uses
- 60 mg (Prolia): osteoporosis in postmenopausal women and in men at increased risk of fractures; bone loss with hormone ablation in prostate cancer; bone loss with long-term systemic glucocorticoid therapy
- 120 mg (Xgeva): prevention of skeletal-related events in adults with advanced malignancies involving bone; giant cell tumour of bone
- Storage (unopened)
- Store in a refrigerator (2 °C to 8 °C). Do not freeze. Keep in the outer carton to protect from light.
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Cold-chain shipment for this refrigerated product.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Prolia and Xgeva: www.ema.europa.eu
- Product information (second product): www.ema.europa.eu